ChemLex是一家以新加坡为基地的化学AI启动项目,筹集了4 500万美元,用于在全球扩大其AI驱动的药物发现实验室。 ChemLex, a Singapore-based chemistry AI startup, raised $45 million to expand its AI-powered drug discovery labs globally.

ChemLex,一个化学AI启动项目,筹集了4 500万美元,由亚洲Granite公司牵头,并在新加坡建立了全球总部,利用AI动力机器人推进药物和材料发现。 ChemLex, a chemistry AI startup, raised $45 million led by Granite Asia and established its global headquarters in Singapore to advance drug and materials discovery using AI-powered robotics. 该公司的自驾实验室可以在一天之内产生相当于三年人工工作的数据,为70多个全球客户提供服务,包括世界前10家制药公司中的6家。 The company’s self-driving lab can generate data equivalent to three years of manual work in a single day, serving over 70 global clients, including six of the world’s top 10 pharma firms. 资金将支持新加坡的招聘工作,并扩大其从上海到新加坡的自动化实验室。 Funds will support hiring in Singapore and expanding its automated lab from Shanghai to Singapore. ChemLex只对AI进行自己的实验培训,并与新加坡的实验药物发展中心合作,促进小分子药物的发现,以此确保数据隐私。 ChemLex ensures data privacy by training its AI only on its own experiments and has partnered with Singapore’s Experimental Drug Development Centre to boost small-molecule drug discovery. 该公司的目标是迅速增长的AI驱动药物发现市场,预计到2034年将达到500亿美元。 The company targets the rapidly growing AI-driven drug discovery market, projected to reach $50 billion by 2034.